EMA’s Pilot On Bespoke Scientific Advice For Biosimilars Attracts Monoclonal Antibody Makers
Executive Summary
Monoclonal antibody developers are showing interest in the European Medicines Agency’s pilot project that is offering bespoke scientific advice on biosimilars.